CN102416079A - Chinese patent medicine for treating leucoderma - Google Patents
Chinese patent medicine for treating leucoderma Download PDFInfo
- Publication number
- CN102416079A CN102416079A CN2011104036935A CN201110403693A CN102416079A CN 102416079 A CN102416079 A CN 102416079A CN 2011104036935 A CN2011104036935 A CN 2011104036935A CN 201110403693 A CN201110403693 A CN 201110403693A CN 102416079 A CN102416079 A CN 102416079A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese patent
- medicine
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese patent medicine for treating leucoderma. The Chinese patent medicine consists of eclipta alba, tuber fleeceflower root, Chinese angelica, szechuan lovage rhizome, astragalus, largehead atractylodes rhizome, tuckahoe, glossy privet fruit, black sesame, suberect spatholobus stem, divaricate saposhnikovia root, fineleaf schizonepeta herb, red paeony root, flowery knotweed stem, knotweed, saffron, tribulus fruit, black soybean hull, malaytea scurfpea fruit and liquoric root, wherein various formulations for oral administration are prepared from the Chinese medicines according to the conventional preparation method. Compared with the prior art, the Chinese patent medicine has the effects of warming and invigorating liver and kidney, dispelling wind and removing rheumatism, regulating qi and blood, clearing and activating channels and collaterals, promoting blood circulation and removing blood stasis, regulating an immunologic function and improving skin microcirculation, and has the outstanding substantial characteristics and obvious improvement of definite curative effects on the treatment and prevention of leucoderma, convenience for administration and the like.
Description
Technical field
The present invention relates to the treatment technology field of cutaneous diseases, relate in particular to a kind of technical field of Chinese medicines of treating the vitiligo disease.
Background technology
Vitiligo is a kind of common posteriority, circumscribed depigmentation dermatoses, can betide any age, is more common in child and youth.The sick limitation decolouring speckle that decreases to differing in size, clear-cut margin, on every side with the healthy skin intersection, color of the leather is denseer; Kainogenesis damages common have temporary inflammatory halo, number or single-shot or pilosity on every side, can merge each other in flakes, and the affected part hair can bleach, and does not have any subjective symptoms, and damaging part has bright gargalesthesia after the Exposure to Sunlight.Primary disease is relevant with various autoimmune property disease, like some patients with vitiligo or its relatives, can be associated with hyperthyroidism and go down, diabetes etc.; The organ specific antibody of finding thyroid, stomach, adrenal tissue in some patient's the blood exists.Primary disease often has family history, has family's genetic predisposition.In addition, with body in copper, zinc ion content lower relevant.The patient is many to increase with perspiration, the performance increase in temperature, and diseases such as bleeding time prolongation, the reason that takes place as the vitiligo disease belongs to blood deficiency and blood stasis wind-engaging person more.
At present, it is a lot of to treat this sick method and medicine, but can not reach ideal effect, Therapeutic Method such as " laser ", " skin-grafting ", " freezing " for example, and not only weak curative effect is returned skin and is stayed scar; Some medicine such as patent medicine: the speckle removing ball, remove Bai Su, white macula tincture etc.; These medicines existence take effect slowly, the course of treatment is long; Cure rate low with shortcoming such as relapse rate height; The medicine that has also has irritated and slight toxic reaction, and the medicine that also has is prone to cause side effect such as liver,kidney,spleen enlargement, brings misery to the patient.
Summary of the invention
Technical problem to be solved by this invention provides a kind of to eliminate patient's illness, and the promotion physical and mental health has the leukodermic Chinese medicine of treatment that the patient takes medicine conveniently, curative effect is fast, have no side effect simultaneously.
For solving the problems of the technologies described above; The present invention adopts following technical scheme: the leukodermic Chinese patent medicine of a kind of treatment, its special character is to be processed by the medicine of following weight proportioning: Herba Ecliptae 20-50 part, Radix Polygoni Multiflori 15-45 part, Radix Angelicae Sinensis 30-60 part, Rhizoma Chuanxiong 15-45 part, Radix Astragali 20-50 part, Rhizoma Atractylodis Macrocephalae 15-45 part, Poria 15-45 part, Fructus Ligustri Lucidi 15-45 part, Semen Sesami Nigrum 20-50 part, Caulis Spatholobi 30-60 part, windproof 30-60 part, Herba Schizonepetae 30-60 part, Radix Paeoniae Rubra 20-50 part, Caulis Polygoni Multiflori 20-50 part, Pericarpium Citri Reticulatae 15-45 part, Stigma Croci 10-30 part, Fructus Atriplicis Sibiricae 30-60 part, Testa sojae atricolor 30-60 part, Fructus Psoraleae 15-45 part, Radix Glycyrrhizae 5-35 part.
For further solving the problems of the technologies described above; The medicine of the above-mentioned weight proportion of the leukodermic Chinese medicine of treatment of the present invention, its preferred version is: Herba Ecliptae 30-40 part, Radix Polygoni Multiflori 25-35 part, Radix Angelicae Sinensis 40-50 part, Rhizoma Chuanxiong 25-35 part, Radix Astragali 30-40 part, Rhizoma Atractylodis Macrocephalae 25-35 part, Poria 25-35 part, Fructus Ligustri Lucidi 25-35 part, Semen Sesami Nigrum 30-40 part, Caulis Spatholobi 40-50 part, windproof 40-50 part, Herba Schizonepetae 40-50 part, Radix Paeoniae Rubra 30-40 part, Caulis Polygoni Multiflori 30-40 part, Pericarpium Citri Reticulatae 25-35 part, Stigma Croci 15-25 part, Fructus Atriplicis Sibiricae 40-50 part, Testa sojae atricolor 40-50 part, Fructus Psoraleae 25-35 part, Radix Glycyrrhizae 15-25 part.
For further solving the problems of the technologies described above; The medicine of the above-mentioned weight proportion of the leukodermic Chinese medicine of treatment of the present invention, its preferred plan is: 35 parts of Herba Ecliptaes, 30 parts of Radix Polygoni Multiflori, 45 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Chuanxiong, 35 parts of the Radixs Astragali, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts in Poria, 30 parts of Fructus Ligustri Lucidi, 35 parts of Semen Sesami Nigrums, 45 parts of Caulis Spatholobis, windproof 45 parts, 45 parts of Herba Schizonepetae, 35 parts of Radix Paeoniae Rubra, 35 parts of Caulis Polygoni Multiflori, 30 parts of Pericarpium Citri Reticulataes, 20 parts of Stigma Crocis, 45 parts of Fructus Atriplicis Sibiricaees, 45 parts of Testa sojae atricolors, 30 parts of Fructus Psoraleaes, 20 parts in Radix Glycyrrhizae.
Above-mentioned described Chinese patent medicine is processed pill, sublimed preparation, powder, tablet, unguentum, decoction and the different oral medicine dosage form of capsule dress powder according to the conventional technology of preparing of Chinese medicine.
Above-mentioned described Chinese patent medicine also contains drug excipient.
The principles of formulating prescriptions of Chinese medicine of the present invention are: nourish liver spleen, replenishing QI to invigorate the spleen, nourshing blood and promoting blood circulation, dredge the meridian passage, blood circulation promoting and blood stasis dispelling, set upright and get rid of evils, regulate immunologic function, improve skin microcirculation, reach the leukodermic purpose of treatment.The present invention has proper, the reasonable recipe of compatibility of drugs, and the effect of its said each herbal medicine is:
Herba Ecliptae: another name: Nanjing grass, Alternanthera sessilis (L.) DC., yerbadetajo seed, Fructus seu radix camptothecae acuminatae (Fructus Camptothecae Acuminatae), Herba Ecliptae, Fructus seu radix camptothecae acuminatae (Fructus Camptothecae Acuminatae) are fluffy etc. in vain; Sweet in the mouth, acid, cool in nature; Return liver, kidney channel, have liver and kidney tonifying; The effect of cooling blood for hemostasis; Main deficiency of the liver and kindey, have a dizzy spell, early whitening of beard and hair, haematemesis, spitting of blood, epistaxis, have blood in stool, dysentery, collapse, disease such as leakage, traumatic hemorrhage.
Radix Polygoni Multiflori: sweetness and bitterness, puckery, slightly warm in nature is returned liver, kidney channel, has nourishing the blood and yin, loosening bowel to relieve constipation, preventing the attack (or recurrence) of malaria, dispels the wind, the antidotal effect.Cure mainly a little less than the waist knee joint acid of blood deficiency Light-headedness, cardiopalmus, insomnia, the hepatic and renal YIN deficiency; Early whitening of beard and hair, tinnitus, seminal emission, dryness of the intestine constipation; The chronic malaria body is empty; Diseases such as rubella pruritus, carbuncle sore, scrofula, hemorrhoid.
Radix Angelicae Sinensis: hot, the little hardship, warm in nature of sweet in the mouth, return liver spleen heart channel, having enriches blood invigorate blood circulation he, the effect of menstruction regulating and pain relieving, these the article diseases such as row is stagnant, menstruction regulating and pain relieving of can nourishing blood with the Rhizoma Chuanxiong compatibility;
Rhizoma Chuanxiong: acrid in the mouth, warm in nature, the effect of promoting flow of QI and blood, wind-expelling pain-stopping is arranged, be used to treat diseases such as menoxenia, amenorrhea dysmenorrhea 、 WEIJIA stomachache, costa sternales twinge, treating swelling and pain by traumatic injury, headache, rheumatic arthralgia;
The Radix Astragali: flavor: sweet, tepor.Return lung, spleen, liver, kidney channel.Effect cures mainly: the Radix Astragali has benefiting QI for strengthening the superficies, arresting sweating to take off, hold in the palm the effect of skin ulcer granulation promoting, inducing diuresis to remove edema admittedly.It is weak to be used to treat the deficiency of vital energy, sinking of QI of middle-JIAO, and the chronic diarrhea proctoptosis, the metrorrhagia of having blood in stool, the exterior deficiency spontaneous perspiration, carbuncle is difficult bursts, and burst for a long time and do not hold back, blood deficiency and yellow complexion, interior-heat is quenched one's thirst, chronic nephritis, albuminuria, diabetes etc.
The Rhizoma Atractylodis Macrocephalae: meridian distribution of property and flavor: bitter, sweet, temperature.Return spleen, stomach warp.Function cures mainly: invigorating the spleen and benefiting QI, and the dampness diuretic, hidroschesis, antiabortive.Be used for insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.
Poria: sweet in the mouth, light; Property is put down; GUIXIN, spleen, lung, kidney channel; Effect: eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming; Cure mainly: dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, insufficiency of the spleen lack of appetite, have loose bowels, palpitation and restlessness, insomnia forgetfulness, seminal emission nebulousurine.
Fructus Ligustri Lucidi: sweet-bitter flavor, cold nature, return the Liver and kidney warp, have nourishing the liver and kidney, the effect that black hair makes eye bright, these article go into Liver and kidney can benefiting essence-blood, black beard and hair, Pingyin fire, reducing the asthenic fever, is usually used in treating deficiency of the liver and kindey and causes disease.
Semen Sesami Nigrum: the black seed for the Pedaliaceae sesame, contain great amount of fat and protein, also have nutritional labelings such as saccharide, vitamin A, vitamin E, lecithin, calcium, ferrum, chromium.Property is sweet, flavor is flat, returns liver, kidney, large intestine channel.Effect: invigorating the liver and kidney, benefiting essence-blood, intestine moistening is dry; Cure mainly: be used for dizziness and blurred vision, Hiccough and deaf, early whitening of beard and hair, post disease alopecia, dryness of the intestine constipation.
Caulis Spatholobi: bitter sweet, warm in nature.Go into the heart, spleen two warps.The effect of Caulis Spatholobi is invigorated blood circulation, Shujin.Control soreness of waist and knee joint, paralysis and numbness, diseases such as menoxenia.
Windproof: as acrid in the mouth, sweet, slightly warm in nature, to return bladder, liver, spleen channel, have the effect of expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion, be used to treat diseases such as diseases caused by exogenous pathogenic factor exterior syndrome, rubella pruritus, rheumatic arthralgia, tetanus.
Herba Schizonepetae: acrid in the mouth, slightly warm in nature, return lung, Liver Channel, have the diffusing wind that induces sweat, rash, the skin ulcer that disappears, hemostatic effect, be usually used in treatment flu, measles pass through send out smooth, have blood in stool, diseases such as metrorrhagia, epistaxis.
Radix Paeoniae Rubra: nature and flavor are bitter, are slightly cold.Return Liver Channel.Function with cure mainly: clearing away heat and cooling blood, eliminating stasis to stop pain.Be used for maculae caused by violent heat pathogen, hematemesis and epistaxis, conjunctival congestion and swelling pain, hypochondriac pain due to stagnation of liverQI, amenorrhea dysmenorrhea, abdominal mass stomachache, injury from falling down, carbuncle skin infection.
Caulis Polygoni Multiflori: matter is crisp, frangible, and section skin zone aubergine, woody part yellow-white or light brown, guide hole is obvious, and marrow is loose, white.Odorless, mildly bitter flavor is puckery.Nature and flavor: sweet, flat.GUIXIN, Liver Channel.Function with cure mainly: nourishing blood to tranquillize the mind, dispelling wind and removing obstruction in the collateral.Be used for insomnia and dreamful sleep, blood deficiency general pain, rheumatic arthralgia; The external treatment skin pruritus.
Pericarpium Citri Reticulatae: warm in nature, bitter in the mouth, suffering.Function cures mainly, regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.Be used for fullness in the epigastrium and chest, lack of appetite and vomiting, cough ant phlegm.
Stigma Croci: sweet in the mouth, property are put down, and have the effect of blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens.Be usually used in treating that the chest and diaphragm painful abdominal mass is vexed, haematemesis, typhoid fever are gone mad, frightenedly be afraid of in a trance, women's amenorrhea, diseases such as postnatal blood stasis stomachache, treating swelling and pain by traumatic injury.
Fructus Atriplicis Sibiricae: slightly warm in nature, acrid in the mouth, hardship; Function cures mainly: the suppressing the hyperactive liver resolving depression, promoting blood circulation by removing wind makes eye bright, and is antipruritic.Be used to have a headache dizzy, distending pain in the chest and hypochondrium, breast closes acute mastitis, conjunctival congestion cataracta, rubella pruritus.
Testa sojae atricolor: Chinese medicine is claimed " material bean clothing ", nature and flavor: sweet, flat.Return liver, kidney channel.Function effect: nourishing YIN and benefiting blood, suppressing the hyperactive liver kidney tonifying; Be applicable to deficiency of liver-blood, blood-deficiency leading to hyperactivity of the liver, or dizzy, the nourishing YIN and clearing away heat of the headache due to the hyperactivity of YANG due to deficiency of YIN; Be used for deficiency of YIN hectic fever night sweat.The traditional Chinese medical science has constantly held, and Semen sojae atricolor is the paddy of kidney, goes into kidney.Has invigorating spleen for diuresis, the detumescence therapeutic method to keep the adverse QI flowing downwards; Nourishing kidney-yin, lung moistening is dry, makes wind heat and promoting blood circulation and detoxication; End night sweat, the function of black hair hair color and life lengthening.
Fructus Psoraleae: acrid in the mouth, warm in nature, nontoxic; Effect with enriching yin and nourishing kidney is usually used in that Yuanyang declines that damage, five kinds of strain and seven kinds of impairment, lumbago due to renal deficiency, kidney qi deficiency and coldness, vital essence are solid, the enuresis, spleen suffer from a deficiency of the kidney and rush down, watery diarrhea chronic dysentery, pregnant woman's lumbago, fall and weigh down diseases such as lumbago, blood stasis stagnate;
Radix Glycyrrhizae: sweet in the mouth, property is flat.GUIXIN, lung, spleen, stomach warp.Function cures mainly: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Be used for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", and all composition comes from the 5th edition medicine that records of China's " pharmacopeia ", and all medicines have the temperature compensation Liver and kidney mutually and altogether, the wind dehumidifying of loosing; The QI and blood regulating, is set upright and is got rid of evils dredge the meridian passage, blood circulation promoting and blood stasis dispelling, regulates immunologic function; Improve skin microcirculation, promote skin pigment to generate the effect of the white and moist skin that disappears; Treatment and prevention vitiligo, determined curative effect have no side effect various Chinese medicine preparation taking conveniences.
Clinical drug of the present invention uses the result to show to have following advantage:
1, the Chinese medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment and the prevention vitiligo of the Chinese medicine of respectively distinguishing the flavor of, and is harmless to human non-toxic.Acute toxicity test and accumulation toxicity test through white mice and rat show that underproof animal does not see any toxic reaction; Compare zero difference through anatomic observation hemogram, liver function, each organs and tissues morphology finding and matched group, prove that its safety of medicine is reliable.
2, Chinese medicine preparation of the present invention need not decoct, not have bitterness sense; Rich in proteins, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid in the medicine; Also contain various trace elements such as Saponin, plant sterol, calcium; Help absorption of human body, health invigorating, and taking convenience.
But 3, Chinese medicine preparation of the present invention efficacious therapy vitiligo not only; And it is also very obvious to leukodermic preventive effect; Particularly pass through working in coordination with each other between the medicine, strengthen medicine and treat characteristic separately, through dredge the meridian passage and adjusting immunologic function; Improve the intrinsic healthy energy of patient body and physical and mental health and life quality, reached the healing rehabilitation efficacy preferably.
Further specify medicine of the present invention to treatment therapy for vitiligo effect through the clinical practice example below.
One, clinical diagnosis standard:
Leukodermic clinical manifestation is: the skin of any department of whole body all can take place, but originates from solar radiation and the damage by friction portion of being prone to, and also can involve like the inboard mucosa of facial area, cervical region, trunk and extremity, lip, labia, glans penis and foreskin.Most of leukasmus is symmetrically distributed, and also has part patient white macula to distribute along nerve segment.Skin lesion is locality depigmentation speckle, milky, big or small from fingernail to coin, circular, oval or irregular shape.White macula place hair also can bleach.In progressive stage, the decolouring speckle is divided a word with a hyphen at the end of a line to normal skin, and development is very fast, and isomorphic response is arranged, and promptly can form the secondary vitiligo after pressure, friction, the wound.
Can divide three types according to the leukoderma scope with distributing:
1, limitation: skin lesion is confined to a position, can be divided into again: (1) segmental pattern: skin lesion is pressed dermatomere and is distributed; (2) mucosal pattern: only involve mucosa.
2, general hair style: the most common, show as skin lesion and be distributed widely in body surface, can be divided into:
(1) homeliness type: skin lesion is dispersed in and is distributed in the body surface many places;
(2) face acra type: skin lesion is distributed in face and far-end of limb;
(3) mixed type: above-mentioned several kinds of various combinations form, like face acra type+segmental pattern etc.
3, whole body type: whole skin all decolours fully or almost, also has hair to bleach.
Two, case selection
Leukodermic sickness rate is with area, the ethnic group colour of skin and different, and the dark more people's sickness rate of general colour is high more.Prevalence is about 0.1-2% in the population of China, and M-F can be fallen ill from the newborn baby about equally until old every year, but is many with teenager.Put down in writing according to interrelated data: age of onset is in the majority in 10-30 year, accounts for 62.65% of sum, and women's age of onset was than male about 5 years ahead of time.For this reason, case selection is whole cases with door rash prescription on individual diagnosis patient.
Three, curative effect determinate standard
Before the curative effect determinate standard that not have at present the promulgation of formal country, the vitiligo curative effect determinate standard that the present invention adopts (the scientific and technological publishing house of Chen Qin chief editor " research and development of Chinese medicine cosmetic health product " Chinese Medicine 1999 version the 228th page) is:
(1) recovery from illness: the white macula complete obiteration, histopathology of skin's inspection is normal;
(2) produce effects: white macula disappears more than 50%, and white macula disappearance portion of tissue pathological examination is normal;
(3) effective: white macula disappearance person accounts for the 20-50% of former white macula area, or in white macula, sees have than the polychrom island;
(4) invalid: no change or white macula enlarge before and after the treatment.
Four, clinical application method and therapeutic outcome
1, clinical application method
According to patient's sick time, the cause of disease and white macula scope and distribution situation, the component medication:
Take the tablet of embodiment 4, each 3-7 gram, every day 2-3 time, warm water delivery service, take half an hour ante cibum.Two months is a course of treatment, take continuously three the course of treatment observe the curative effect.
2, therapeutic outcome
Amount to 56 examples through clinical diagnosis treatment patients with vitiligo, male's 26 examples, women's 30 examples, the age is 12-50 year.Recovery from illness 26 examples account for 46.4% among the 56 routine patients, and produce effects 17 examples account for 30.4%, and effective 9 examples account for 16.1%, and invalid 4 examples account for 7.1%, and total effective rate reaches 92.9%.After treatment, the patient skin white macula disappears in various degree or fully recover, and patient do not have any untoward reaction, three big routine tests and hepatic and renal function detection do not find any unusually.Fully recover through the patient and to pay a return visit statistics, do not see an example recurrence so far.
The specific embodiment
Embodiment 1
Press the row weight portion and take by weighing each Chinese crude drug: 20 parts of Herba Ecliptaes, 15 parts of Radix Polygoni Multiflori, 30 parts of Radix Angelicae Sinensis, 15 parts of Rhizoma Chuanxiong, 20 parts of the Radixs Astragali, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts in Poria, 15 parts of Fructus Ligustri Lucidi, 20 parts of Semen Sesami Nigrums, 30 parts of Caulis Spatholobis, windproof 30 parts, 30 parts of Herba Schizonepetae, 20 parts of Radix Paeoniae Rubra, 20 parts of Caulis Polygoni Multiflori, 15 parts of Pericarpium Citri Reticulataes, 10 parts of Stigma Crocis, 30 parts of Fructus Atriplicis Sibiricaees, 30 parts of Testa sojae atricolors, 15 parts of Fructus Psoraleaes, 5 parts in Radix Glycyrrhizae.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed sublimed preparation according to the pharmaceutical methods that routine prepares sublimed preparation.
Embodiment 2
Press the row weight portion and take by weighing each medical material: 50 parts of Herba Ecliptaes, 45 parts of Radix Polygoni Multiflori, 60 parts of Radix Angelicae Sinensis, 45 parts of Rhizoma Chuanxiong, 50 parts of the Radixs Astragali, 45 parts of the Rhizoma Atractylodis Macrocephalaes, 45 parts in Poria, 45 parts of Fructus Ligustri Lucidi, 50 parts of Semen Sesami Nigrums, 60 parts of Caulis Spatholobis, windproof 60 parts, 60 parts of Herba Schizonepetae, 50 parts of Radix Paeoniae Rubra, 50 parts of Caulis Polygoni Multiflori, 45 parts of Pericarpium Citri Reticulataes, 30 parts of Stigma Crocis, 60 parts of Fructus Atriplicis Sibiricaees, 60 parts of Testa sojae atricolors, 45 parts of Fructus Psoraleaes, 35 parts in Radix Glycyrrhizae.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed packed powder according to the pharmaceutical methods that routine prepares powder.
Embodiment 3
Press the row weight portion and take by weighing each medical material: 30 parts of Herba Ecliptaes, 25 parts of Radix Polygoni Multiflori, 40 parts of Radix Angelicae Sinensis, 25 parts of Rhizoma Chuanxiong, 30 parts of the Radixs Astragali, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 25 parts in Poria, 25 parts of Fructus Ligustri Lucidi, 30 parts of Semen Sesami Nigrums, 40 parts of Caulis Spatholobis, windproof 40 parts, 40 parts of Herba Schizonepetae, 30 parts of Radix Paeoniae Rubra, 30 parts of Caulis Polygoni Multiflori, 25 parts of Pericarpium Citri Reticulataes, 15 parts of Stigma Crocis, 40 parts of Fructus Atriplicis Sibiricaees, 40 parts of Testa sojae atricolors, 25 parts of Fructus Psoraleaes, 15 parts in Radix Glycyrrhizae.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed capsule according to the pharmaceutical methods that routine prepares capsule.
Embodiment 4
Press the row weight portion and take by weighing each medical material: 40 parts of Herba Ecliptaes, 35 parts of Radix Polygoni Multiflori, 50 parts of Radix Angelicae Sinensis, 35 parts of Rhizoma Chuanxiong, 40 parts of the Radixs Astragali, 35 parts of the Rhizoma Atractylodis Macrocephalaes, 35 parts in Poria, 35 parts of Fructus Ligustri Lucidi, 40 parts of Semen Sesami Nigrums, 50 parts of Caulis Spatholobis, windproof 50 parts, 50 parts of Herba Schizonepetae, 40 parts of Radix Paeoniae Rubra, 40 parts of Caulis Polygoni Multiflori, 35 parts of Pericarpium Citri Reticulataes, 25 parts of Stigma Crocis, 50 parts of Fructus Atriplicis Sibiricaees, 50 parts of Testa sojae atricolors, 35 parts of Fructus Psoraleaes, 25 parts in Radix Glycyrrhizae.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed tablet according to the pharmaceutical methods that routine prepares tablet; (like conventional tablet, sugar coated tablet, film coated tablet etc.), and give conventional drug excipient (like starch, sucrose, lactose, calcium stearate, magnesium stearate etc.).
Embodiment 5
Press the row weight portion and take by weighing each medical material: 35 parts of Herba Ecliptaes, 30 parts of Radix Polygoni Multiflori, 45 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Chuanxiong, 35 parts of the Radixs Astragali, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts in Poria, 30 parts of Fructus Ligustri Lucidi, 35 parts of Semen Sesami Nigrums, 45 parts of Caulis Spatholobis, windproof 45 parts, 45 parts of Herba Schizonepetae, 35 parts of Radix Paeoniae Rubra, 35 parts of Caulis Polygoni Multiflori, 30 parts of Pericarpium Citri Reticulataes, 20 parts of Stigma Crocis, 45 parts of Fructus Atriplicis Sibiricaees, 45 parts of Testa sojae atricolors, 30 parts of Fructus Psoraleaes, 20 parts in Radix Glycyrrhizae.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed pill according to the pharmaceutical methods that routine prepares pill, and give conventional drug excipient.
Embodiment 6
Press the row weight portion and take by weighing each medical material: 40 parts of Herba Ecliptaes, 30 parts of Radix Polygoni Multiflori, 45 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Chuanxiong, 40 parts of the Radixs Astragali, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts in Poria, 30 parts of Fructus Ligustri Lucidi, 40 parts of Semen Sesami Nigrums, 45 parts of Caulis Spatholobis, windproof 45 parts, 45 parts of Herba Schizonepetae, 40 parts of Radix Paeoniae Rubra, 40 parts of Caulis Polygoni Multiflori, 30 parts of Pericarpium Citri Reticulataes, 20 parts of Stigma Crocis, 45 parts of Fructus Atriplicis Sibiricaees, 45 parts of Testa sojae atricolors, 30 parts of Fructus Psoraleaes, 20 parts in Radix Glycyrrhizae.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed granule according to the pharmaceutical methods that routine prepares granule.
Claims (5)
1. the leukodermic Chinese patent medicine of treatment is characterized in that being processed by the medicine of following weight proportioning: Herba Ecliptae 20-50 part, Radix Polygoni Multiflori 15-45 part, Radix Angelicae Sinensis 30-60 part, Rhizoma Chuanxiong 15-45 part, Radix Astragali 20-50 part, Rhizoma Atractylodis Macrocephalae 15-45 part, Poria 15-45 part, Fructus Ligustri Lucidi 15-45 part, Semen Sesami Nigrum 20-50 part, Caulis Spatholobi 30-60 part, windproof 30-60 part, Herba Schizonepetae 30-60 part, Radix Paeoniae Rubra 20-50 part, Caulis Polygoni Multiflori 20-50 part, Pericarpium Citri Reticulatae 15-45 part, Stigma Croci 10-30 part, Fructus Atriplicis Sibiricae 30-60 part, Testa sojae atricolor 30-60 part, Fructus Psoraleae 15-45 part, Radix Glycyrrhizae 5-35 part.
2. the leukodermic Chinese patent medicine of a kind of treatment according to claim 1 is characterized in that being processed by the medicine of following weight proportioning: Herba Ecliptae 30-40 part, Radix Polygoni Multiflori 25-35 part, Radix Angelicae Sinensis 40-50 part, Rhizoma Chuanxiong 25-35 part, Radix Astragali 30-40 part, Rhizoma Atractylodis Macrocephalae 25-35 part, Poria 25-35 part, Fructus Ligustri Lucidi 25-35 part, Semen Sesami Nigrum 30-40 part, Caulis Spatholobi 40-50 part, windproof 40-50 part, Herba Schizonepetae 40-50 part, Radix Paeoniae Rubra 30-40 part, Caulis Polygoni Multiflori 30-40 part, Pericarpium Citri Reticulatae 25-35 part, Stigma Croci 15-25 part, Fructus Atriplicis Sibiricae 40-50 part, Testa sojae atricolor 40-50 part, Fructus Psoraleae 25-35 part, Radix Glycyrrhizae 15-25 part.
3. the leukodermic Chinese patent medicine of a kind of treatment according to claim 1 is characterized in that being processed by the medicine of following weight proportioning: 35 parts of Herba Ecliptaes, 30 parts of Radix Polygoni Multiflori, 45 parts of Radix Angelicae Sinensis, 30 parts of Rhizoma Chuanxiong, 35 parts of the Radixs Astragali, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts in Poria, 30 parts of Fructus Ligustri Lucidi, 35 parts of Semen Sesami Nigrums, 45 parts of Caulis Spatholobis, windproof 45 parts, 45 parts of Herba Schizonepetae, 35 parts of Radix Paeoniae Rubra, 35 parts of Caulis Polygoni Multiflori, 30 parts of Pericarpium Citri Reticulataes, 20 parts of Stigma Crocis, 45 parts of Fructus Atriplicis Sibiricaees, 45 parts of Testa sojae atricolors, 30 parts of Fructus Psoraleaes, 20 parts in Radix Glycyrrhizae.
4. according to the leukodermic Chinese patent medicine of the described a kind of treatment of arbitrary claim in the claim 1 to 3, it is characterized in that described Chinese patent medicine processes pill, sublimed preparation, powder, tablet, unguentum, decoction and the different oral medicine dosage form of capsule dress powder according to the conventional technology of preparing of Chinese medicine.
5. the leukodermic Chinese patent medicine of a kind of treatment according to claim 4 is characterized in that described Chinese patent medicine also contains drug excipient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104036935A CN102416079A (en) | 2011-11-29 | 2011-11-29 | Chinese patent medicine for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104036935A CN102416079A (en) | 2011-11-29 | 2011-11-29 | Chinese patent medicine for treating leucoderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102416079A true CN102416079A (en) | 2012-04-18 |
Family
ID=45940880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104036935A Pending CN102416079A (en) | 2011-11-29 | 2011-11-29 | Chinese patent medicine for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102416079A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102743580A (en) * | 2012-07-24 | 2012-10-24 | 王华柱 | Chinese medicinal pill for treating vitligo |
| CN103169776A (en) * | 2013-01-25 | 2013-06-26 | 山东中医药大学附属医院 | External medicament for treating leucoderma and preparation method thereof |
| CN103251847A (en) * | 2013-06-05 | 2013-08-21 | 高忠青 | Traditional Chinese medicine for treating leucoderma |
| CN103330834A (en) * | 2013-06-26 | 2013-10-02 | 张秀兰 | Medicine for treating leucoderma and preparation method thereof |
| CN104069190A (en) * | 2014-05-13 | 2014-10-01 | 李宏广 | Traditional Chinese medicament for treating leukoderma |
| CN104147496A (en) * | 2014-08-08 | 2014-11-19 | 徐辉 | Drug for treating leucoderma and preparation method thereof |
| CN104173618A (en) * | 2014-08-08 | 2014-12-03 | 徐辉 | Medicine for treating vitiligo and preparation method of medicine for treating vitiligo |
| CN105560842A (en) * | 2016-03-28 | 2016-05-11 | 姜群群 | Traditional Chinese medicine preparation for treating leucoderma caused by liver and kidney deficiency and wind-damp collateral blockage |
| CN106214960A (en) * | 2016-08-26 | 2016-12-14 | 梁献勇 | For treating leukodermic medicine |
| CN114796352A (en) * | 2021-01-27 | 2022-07-29 | 保定华仁白癜风医院 | Oral liquid for removing white hair and blackening hair |
| CN114796372A (en) * | 2021-01-27 | 2022-07-29 | 保定华仁白癜风医院 | Double-vine whitening-removing pill |
-
2011
- 2011-11-29 CN CN2011104036935A patent/CN102416079A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| 安家丰等: "《张志礼皮肤病医案选萃》", 30 November 1994, 人民卫生出版社 * |
| 张作舟等: "《张作舟》", 30 April 2009, 中国中医药出版社 * |
| 罗和古等: "《经方验方巧治皮肤病》", 31 August 2007, 中国医药科技出版社 * |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102743580A (en) * | 2012-07-24 | 2012-10-24 | 王华柱 | Chinese medicinal pill for treating vitligo |
| CN103169776A (en) * | 2013-01-25 | 2013-06-26 | 山东中医药大学附属医院 | External medicament for treating leucoderma and preparation method thereof |
| CN103251847A (en) * | 2013-06-05 | 2013-08-21 | 高忠青 | Traditional Chinese medicine for treating leucoderma |
| CN103251847B (en) * | 2013-06-05 | 2014-10-22 | 河北工程大学 | Traditional Chinese medicine for treating leucoderma |
| CN103330834B (en) * | 2013-06-26 | 2015-02-18 | 张秀兰 | Medicine for treating leucoderma and preparation method thereof |
| CN103330834A (en) * | 2013-06-26 | 2013-10-02 | 张秀兰 | Medicine for treating leucoderma and preparation method thereof |
| CN104069190A (en) * | 2014-05-13 | 2014-10-01 | 李宏广 | Traditional Chinese medicament for treating leukoderma |
| CN104147496A (en) * | 2014-08-08 | 2014-11-19 | 徐辉 | Drug for treating leucoderma and preparation method thereof |
| CN104173618A (en) * | 2014-08-08 | 2014-12-03 | 徐辉 | Medicine for treating vitiligo and preparation method of medicine for treating vitiligo |
| CN105560842A (en) * | 2016-03-28 | 2016-05-11 | 姜群群 | Traditional Chinese medicine preparation for treating leucoderma caused by liver and kidney deficiency and wind-damp collateral blockage |
| CN105560842B (en) * | 2016-03-28 | 2019-10-01 | 姜群群 | A kind of Chinese materia medica preparation for treating kidney deficiency and liver, rheumatism resistance network type leucoderma |
| CN106214960A (en) * | 2016-08-26 | 2016-12-14 | 梁献勇 | For treating leukodermic medicine |
| CN114796352A (en) * | 2021-01-27 | 2022-07-29 | 保定华仁白癜风医院 | Oral liquid for removing white hair and blackening hair |
| CN114796372A (en) * | 2021-01-27 | 2022-07-29 | 保定华仁白癜风医院 | Double-vine whitening-removing pill |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102416079A (en) | Chinese patent medicine for treating leucoderma | |
| CN104689012A (en) | Kidney reinforcing and bone strengthening wine and making method thereof | |
| CN102362950A (en) | Traditional Chinese medicine for treating leucoderma | |
| CN104352776A (en) | Traditional Chinese medicine preparation for treating infertility caused by hypomenorrhea and preparation method thereof | |
| CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
| CN102362919A (en) | Traditional Chinese medicine for treating scleroderma | |
| CN104524287A (en) | Traditional Chinese medicinal composition for treating anaphylactoid purpura and preparation method of traditional Chinese medicinal composition | |
| CN101912551B (en) | Miscarriage-prevention Chinese medicinal composition | |
| CN103432559A (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN102430013A (en) | Chinese medicine for treating vitiligo | |
| CN101897933B (en) | Chinese patent medicament for treating leucoderma | |
| CN103977281A (en) | Traditional Chinese medicine composition for treating female endocrine disorders and preparation method thereof | |
| CN102727648A (en) | Chinese medicinal composition for treating vitiligo | |
| CN102430097A (en) | Chinese medicine for treating vitiligo | |
| CN102423433A (en) | Traditional Chinese drug mixture for treating psoriasis | |
| CN102406866A (en) | Chinese medicinal composition for treating psoriasis | |
| CN104906507A (en) | Traditional Chinese medicine combination for lowering blood pressure and toning physical fitness | |
| CN104784538A (en) | Chinese medicinal preparation for treating diabetes and preparation method | |
| CN104800771A (en) | Traditional Chinese medicine preparation for treating children sleep terror disorder and preparation method thereof | |
| CN104906430A (en) | Traditional Chinese medicine preparation for treating xerophthalmia and preparation method thereof | |
| CN103690869B (en) | Chinese medicine for the treatment of irritable bowel syndrome and preparation method thereof | |
| CN102406865A (en) | Chinese medicinal composition for treating psoriasis | |
| CN102579895B (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN105125911A (en) | Traditional Chinese medicinal composition for regulating and treating benign prostatic hyperplasia and preparation method of traditional Chinese medicinal composition | |
| CN101085281A (en) | Traditional Chinese medicine for curing chronic nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120418 |